Probiotics in the treatment of infantile colic: a meta-analysis of randomized controlled trials

YanPing Liu1, Dejian Ma2, XiYan Wang3

  • 1Department of Pediatric Gastrointestinal Surgery, The People's Hospital of Zhangqiu.

Nutricion Hospitalaria
|September 22, 2022
PubMed

Insights

Probiotics show promise in treating and preventing infant colic, offering a potential solution for caregivers. Further research confirms their therapeutic benefits within four weeks of treatment.

Area of Science:

  • Pediatrics
  • Microbiology
  • Gastroenterology

Background:

  • Infant colic presents a significant challenge for caregivers, with ongoing debate regarding effective interventions.
  • Research into the use of probiotics for infant colic remains inconclusive.

Purpose of the Study:

  • To evaluate the efficacy of probiotics in the prevention and treatment of infant colic.
  • To synthesize evidence from randomized controlled trials on probiotic use for infantile colic.

Main Methods:

  • A systematic review and meta-analysis of nine randomized controlled trials.
  • Searched major databases (PubMed, Web of Science, Cochrane Library, Medline, Google Scholar) for trials published before November 2021.
  • Data extraction and quality assessment performed by two independent investigators.

Main Results:

  • Eight trials involving 587 infants with colic were included.
  • Probiotics demonstrated a significantly higher effective rate (RR = 1.88, 95% CI: 1.61 to 2.19, p < 0.00001) compared to placebo.
  • The probiotic group included 228 infants, and the placebo group included 227 infants.

Conclusions:

  • Probiotics may offer significant therapeutic and preventive effects for infant colic.
  • The benefits of probiotics appear most pronounced within four weeks of administration.
  • Findings suggest probiotics as a viable option for managing infant colic.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
300
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
274
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
398
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
174
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
73.1K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
193